A Scaffold-Free 3-D Co-Culture Mimics the Major Features of the Reverse Warburg Effect In Vitro.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
13 08 2020
Historique:
received: 19 05 2020
revised: 31 07 2020
accepted: 09 08 2020
entrez: 23 8 2020
pubmed: 23 8 2020
medline: 20 3 2021
Statut: epublish

Résumé

Most tumors consume large amounts of glucose. Concepts to explain the mechanisms that mediate the achievement of this metabolic need have proposed a switch of the tumor mass to aerobic glycolysis. Depending on whether primarily tumor or stroma cells undergo such a commutation, the terms 'Warburg effect' or 'reverse Warburg effect' were coined to describe the underlying biological phenomena. However, current in vitro systems relying on 2-D culture, single cell-type spheroids, or basal-membrane extract (BME/Matrigel)-containing 3-D structures do not thoroughly reflect these processes. Here, we aimed to establish a BME/Matrigel-free 3-D microarray cancer model to recapitulate the metabolic interplay between cancer and stromal cells that allows mechanistic analyses and drug testing. Human HT-29 colon cancer and CCD-1137Sk fibroblast cells were used in mono- and co-cultures as 2-D monolayers, spheroids, and in a cell-chip format. Metabolic patterns were studied with immunofluorescence and confocal microscopy. In chip-based co-cultures, HT-29 cells showed facilitated 3-D growth and increased levels of hexokinase-2, TP53-induced glycolysis and apoptosis regulator (TIGAR), lactate dehydrogenase, and: translocase of outer mitochondrial membrane 20 (TOMM20), when compared with HT-29 mono-cultures. Fibroblasts co-cultured with HT-29 cells expressed higher levels of mono-carboxylate transporter 4, hexokinase-2, microtubule-associated proteins 1A/1B light chain 3, and ubiquitin-binding protein p62 than in fibroblast mono-cultures, in both 2-D cultures and chips. Tetramethylrhodamin-methylester (TMRM) live-cell imaging of chip co-cultures revealed a higher mitochondrial potential in cancer cells than in fibroblasts. The findings demonstrate a crosstalk between cancer cells and fibroblasts that affects cellular growth and metabolism. Chip-based 3-D co-cultures of cancer cells and fibroblasts mimicked features of the reverse Warburg effect.

Identifiants

pubmed: 32823793
pii: cells9081900
doi: 10.3390/cells9081900
pmc: PMC7463893
pii:
doi:

Substances chimiques

MAP1LC3A protein, human 0
Microtubule-Associated Proteins 0
Monocarboxylic Acid Transporters 0
Muscle Proteins 0
SLC16A4 protein, human 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

SLAS Discov. 2017 Jun;22(5):456-472
pubmed: 28520521
Signal Transduct Target Ther. 2018 Nov 30;3:31
pubmed: 30510778
Cancers (Basel). 2015 Dec 11;7(4):2443-58
pubmed: 26690480
J Cell Sci. 2017 Jan 1;130(1):203-218
pubmed: 27663511
Front Oncol. 2018 Aug 24;8:333
pubmed: 30197878
Front Med (Lausanne). 2018 Aug 31;5:234
pubmed: 30234115
N Engl J Med. 2014 Aug 28;371(9):799-807
pubmed: 25162886
Semin Cancer Biol. 2014 Apr;25:47-60
pubmed: 24486645
Int J Cancer. 2011 Apr 15;128(8):1751-7
pubmed: 21344372
Exp Cell Res. 2019 Apr 15;377(1-2):109-114
pubmed: 30794801
PLoS One. 2020 Feb 25;15(2):e0229407
pubmed: 32097436
J Cell Physiol. 2018 Jan;234(1):181-191
pubmed: 30277557
Antioxid Redox Signal. 2012 Jun 1;16(11):1264-84
pubmed: 21883043
Arch Med Sci. 2018 Jun;14(4):910-919
pubmed: 30002710
Semin Oncol. 2017 Jun;44(3):198-203
pubmed: 29248131
Nat Rev Cancer. 2004 Nov;4(11):839-49
pubmed: 15516957
Oncotarget. 2017 May 25;8(34):57813-57825
pubmed: 28915713
Cell Cycle. 2016;15(1):72-83
pubmed: 26636483
J Cell Sci. 2020 Apr 21;133(8):
pubmed: 32317312
Biomed Res Int. 2015;2015:242437
pubmed: 26779534
Nat Rev Cancer. 2004 Nov;4(11):891-9
pubmed: 15516961
Cancer Cell. 2018 Mar 12;33(3):463-479.e10
pubmed: 29455927
Cell. 2016 Jul 28;166(3):555-566
pubmed: 27471965
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
Autophagy. 2016;12(1):1-222
pubmed: 26799652
Curr Opin Genet Dev. 2018 Oct;52:117-122
pubmed: 30261425
World J Stem Cells. 2019 Dec 26;11(12):1065-1083
pubmed: 31875869
Adv Sci (Weinh). 2019 Feb 10;6(8):1801531
pubmed: 31016107
Cancer Metab. 2016 Mar 08;4:5
pubmed: 26962452
Cell Res. 2018 Mar;28(3):265-280
pubmed: 29219147
Sci Adv. 2018 Apr 27;4(4):eaas8998
pubmed: 29719868
Cancer. 2010 Jan 15;116(2):451-8
pubmed: 19924789
Front Oncol. 2019 Feb 05;9:36
pubmed: 30805306
Health Aff (Millwood). 2018 May;37(5):694-701
pubmed: 29733705
Cell Cycle. 2010 Sep 1;9(17):3534-51
pubmed: 20864819
J Cancer. 2019 Aug 7;10(19):4574-4587
pubmed: 31528221
Neoplasia. 2019 Jun;21(6):615-626
pubmed: 31078067
Br J Cancer. 2013 Feb 19;108(3):662-7
pubmed: 23322207
Front Bioeng Biotechnol. 2016 Feb 12;4:12
pubmed: 26904541
Mol Cell Proteomics. 2009 Mar;8(3):443-50
pubmed: 18952599
Biotechnol Bioeng. 2019 Jan;116(1):206-226
pubmed: 30367820
Nutr J. 2012 Mar 26;11:18
pubmed: 22449145
Cell Cycle. 2011 Jun 1;10(11):1772-83
pubmed: 21558814
Front Med (Lausanne). 2019 Jun 27;6:139
pubmed: 31316988
Am J Cancer Res. 2017 May 01;7(5):1107-1135
pubmed: 28560061
Am J Cancer Res. 2018 Oct 01;8(10):1967-1976
pubmed: 30416849
J Vis Exp. 2014 Jul 08;(89):
pubmed: 25046278
Nat Rev Cancer. 2012 Oct;12(10):685-98
pubmed: 23001348
Cell Cycle. 2010 Jun 15;9(12):2423-33
pubmed: 20562526
Front Oncol. 2014 Mar 27;4:62
pubmed: 24734219
Front Mol Biosci. 2020 Feb 21;7:20
pubmed: 32154265

Auteurs

Florian Keller (F)

Institute of Molecular and Cell Biology, Mannheim University of Applied Sciences, 68163 Mannheim, Germany.
Institute of Medical Technology, Medical Faculty Mannheim of Heidelberg University and Mannheim University of Applied Sciences, 68167 Mannheim, Germany.

Roman Bruch (R)

Institute of Molecular and Cell Biology, Mannheim University of Applied Sciences, 68163 Mannheim, Germany.

Richard Schneider (R)

TIP Oncology, Merck Healthcare KGaA, 64289 Darmstadt, Germany.

Julia Meier-Hubberten (J)

TIP Oncology, Merck Healthcare KGaA, 64289 Darmstadt, Germany.

Mathias Hafner (M)

Institute of Molecular and Cell Biology, Mannheim University of Applied Sciences, 68163 Mannheim, Germany.
Institute of Medical Technology, Medical Faculty Mannheim of Heidelberg University and Mannheim University of Applied Sciences, 68167 Mannheim, Germany.

Rüdiger Rudolf (R)

Institute of Molecular and Cell Biology, Mannheim University of Applied Sciences, 68163 Mannheim, Germany.
Institute of Medical Technology, Medical Faculty Mannheim of Heidelberg University and Mannheim University of Applied Sciences, 68167 Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH